MDL | MFCD00865793 |
---|---|
Molecular Weight | 373.45 |
Molecular Formula | C19H27N5O3 |
SMILES | NC1=NC(N2CCN(C(CCC)=O)CCC2)=NC3=CC(OC)=C(OC)C=C13 |
Bunazosin is a potent and selective α1-adrenoceptor antagonist. Bunazosin can be used for antihypertensive and ocular hypotensive research [1] .
α1-adrenergic receptor |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT00130156 | Eisai Inc.|Eisai Co., Ltd. |
High Blood Pressure
|
October 2005 | Phase 4 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 100 mg/mL ( 267.77 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.6777 mL | 13.3887 mL | 26.7773 mL |
5 mM | 0.5355 mL | 2.6777 mL | 5.3555 mL |
10 mM | 0.2678 mL | 1.3389 mL | 2.6777 mL |